This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. DAVID OSGUTHORPE, MD
Charleston, SC

Arch Otolaryngol. 1985;111(3):208.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—A recent article by Clutter et al¹ presented an left orbital roof osteoblastoma removed by curettage. Though no patient follow-up was given, the authors asserted that regression of such tumors occurs in a high percentage of cases after incomplete removal and "may represent a change in the local immune status or merely inactivity of residue tumor." The latter (quote) is conjecture. Very few reports have sufficient follow-up to document cure, given that tumor persistence has manifested up to nine years following surgery. The recent head and neck literature indicates that complete excision of benign osteoblastoma is the therapy of choice.^2-4 As stated by Batsakis,⁵ "incomplete excision will yield recurrence and a non-radical en bloc excision is advised." Of the 14% of osteoblastomas that occur in the head and neck region, curettage has been primarily applied to alveolar arch tumors that can be curetted with . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?